Emmanuel Kokori, G. Olatunji, Abdulbasit Muili Opeyemi, Nicholas Aderinto
{"title":"460 The efficacy and safety of pembrolizumab and dostarlimab in advanced endometrial carcinoma: a systematic review","authors":"Emmanuel Kokori, G. Olatunji, Abdulbasit Muili Opeyemi, Nicholas Aderinto","doi":"10.1136/ijgc-2024-esgo.342","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517833,"journal":{"name":"Poster and E-Posters","volume":"67 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Poster and E-Posters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-esgo.342","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
